Family Search for PF05656 (DUF805)
PF05656 hits 31 sequences in PaperBLAST's database above the trusted cutoff. Showing all hits. Or show only hits to curated sequences or try another family.
YhaH / b3103 putative inner membrane protein from Escherichia coli K-12 substr. MG1655 (see paper)
b3103 predicted inner membrane protein (NCBI) from Escherichia coli str. K-12 substr. MG1655
Aligns to 11:117 / 121 (88.4%), covers 100.0% of PF05656, 121.7 bits
STM3234 putative inner membrane protein (NCBI ptt file) from Salmonella typhimurium LT2
Aligns to 11:117 / 121 (88.4%), covers 100.0% of PF05656, 119.7 bits
- Selection-Driven Gene Inactivation in Salmonella
Cherry, Genome biology and evolution 2020 - “...STM1227 STM3739 STM3114 STM0807 STM1148 STM0130 STM2238 STM0826 STM3234 STM3026 STM0239 STM0839 STM2742 STM0295 cyuP cysK pepT ligB speC ybhL clsC ddlB -- rlmF...”
- The target spectrum of SdsR small RNA in Salmonella
Fröhlich, Nucleic acids research 2016 - “..., 17 ) mopA STM4329 4,26 co-chaperonin GroES (72 to +45 in mopB)::gfp nc yhaH STM3234 3,70 putative inner membrane protein (43 to +45 in yhaH)::gfp FC yes yes ( 14 , 15 ) yhcB STM3347 3,46 cytochrome d ubiquinol oxidase subunit III (59 to +45...”
PMI1438 hypothetical protein (RefSeq) from Proteus mirabilis HI4320
Aligns to 12:125 / 127 (89.8%), covers 100.0% of PF05656, 114.4 bits
YhaI / b3104 putative inner membrane protein from Escherichia coli K-12 substr. MG1655 (see paper)
b3104 predicted inner membrane protein (NCBI) from Escherichia coli str. K-12 substr. MG1655
Z4458 putative cytochrome (NCBI ptt file) from Escherichia coli O157:H7 EDL933
Aligns to 11:113 / 118 (87.3%), covers 100.0% of PF05656, 113.2 bits
PA0563 hypothetical protein (NCBI) from Pseudomonas aeruginosa PAO1
Aligns to 12:113 / 117 (87.2%), covers 100.0% of PF05656, 111.8 bits
- Transcriptional profiling of Pseudomonas aeruginosa mature single- and dual-species biofilms in response to meropenem
Alam, Microbiology (Reading, England) 2023 - “...1.820434031 2.26E-06 7.78E-05 clpV1 1.75537326 1.53E-11 1.37E-09 vgrG1 1.730154359 3.27E-12 3.37E-10 PA4222 1.708263864 2.26E-12 2.45E-10 PA0563 1.691305244 1.68E-11 1.47E-09 PA0086 1.677560955 4.89E-10 3.46E-08 Downregulated PA0627 2.524464134 1.52E-15 2.79E-13 gfnR 2.418533396 8.72E-23 8.02E-20 PA0641 2.404904976 2.04E-20 7.49E-18 PA0638 2.364308134 4.30E-21 1.98E-18 PA0628 2.298437047 1.97E-20 7.49E-18 PA0635 2.263949045...”
- The Small RNA ErsA Impacts the Anaerobic Metabolism of Pseudomonas aeruginosa Through Post-Transcriptional Modulation of the Master Regulator Anr
Ferrara, Frontiers in microbiology 2021 - “...D 2.02 U U Trunk et al., 2010 ; Tribelli et al., 2019 Membrane proteins PA0563 membrane protein U 1.50 D D Trunk et al., 2010 PA1429 probable cation-transporting P-type ATPase D 2.27 U Alvarez-Ortega and Harwood, 2007 ; Tribelli et al., 2019 PA1337 ansB ,...”
- Transcriptional Responses of Pseudomonas aeruginosa to Inhibition of Lipoprotein Transport by a Small Molecule Inhibitor.
Lorenz, Journal of bacteriology 2020 - “...4.3 4.7 Hypothetical protein PA1657 hsiB2 4.3 3.7 HsiB2 PA3912 4.2 3.1 Conserved hypothetical protein PA0563 4.2 4.9 Conserved hypothetical protein PA1868 xqhA 4.2 6.6 Secretion protein XqhA PA1659 hsiF2 4.2 3.2 HsiF2 PA1082 flgG 4.1 3.9 Flagellar basal body rod protein FlgG PA1077 flgB 4.0...”
- Transcriptome analysis of Pseudomonas aeruginosa PAO1 grown at both body and elevated temperatures
Chan, PeerJ 2016 - “...10.9322 1.89052 2.53173 2.42142 0.00025 0.00268304 gene4330 rplV 73.7324 13.723 2.4257 2.23755 0.0036 0.0243101 gene568 PA0563 74.2912 14.1381 2.39361 2.52297 0.00425 0.0258005 gene4663 PA4571 13.6487 2.62789 2.37679 3.4702 5.00E-05 0.00069884 gene4324 rplX 126.547 24.3781 2.37602 2.89574 0.0001 0.00130652 gene4331 rpsS 993.38 192.891 2.36456 3.71984 5.00E-05 0.00069884...”
plu2346 No description from Photorhabdus luminescens subsp. laumondii TTO1
Aligns to 11:118 / 122 (88.5%), covers 99.0% of PF05656, 104.5 bits
PGN_0306 hypothetical protein (RefSeq) from Porphyromonas gingivalis ATCC 33277
Aligns to 112:265 / 280 (55.0%), covers 100.0% of PF05656, 101.8 bits
BC2001 Integral membrane protein (NCBI ptt file) from Bacillus cereus ATCC 14579
Aligns to 11:112 / 120 (85.0%), covers 100.0% of PF05656, 100.5 bits
- Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review
Lemiński, Journal of clinical medicine 2023 - “...on CMT The efficacy and safety of chemoradiation for MIBC have been evaluated in the BC2001 prospective randomized controlled trial, which showed the advantage of radiotherapy (RT) combined with chemotherapy with 5-fluorouracil and mitomycin C (5-FU + MMC) over RT alone in terms of local disease...”
- “...this benefit extends to patients undergoing CMT. The available level 1 evidence originating from the BC2001 trial corroborated the feasibility and good tolerance of NAC with subsequent CRT or radiotherapy, but the study lacked the power to detect the eventual survival benefit associated with NAC in...”
- Mapping Local Failure Following Bladder Radiotherapy According to Dose
Abdel-Aty, Clinical oncology (Royal College of Radiologists (Great Britain)) 2022 - “...dose escalation [ 14 , 15 ]. In the partial 2 2 factorial design of BC2001, patients were randomised to either conventional whole bladder radiotherapy or a reduced high-dose radiation volume to the bladder tumour [ 16 ]. Consistent with earlier data, it successfully showed that...”
- “...prior to radiotherapy. Radiotherapy was delivered with concomitant chemotherapy wherever possible, following reporting of the BC2001 trial [ 3 ]. Radiotherapy planning computed tomography (CT) was acquired with an empty bladder. Target structures included the bladder tumour (GTV), whole bladder (CTV bladder ), pelvic nodes (CTV...”
- A review of the biology and therapeutic implications of cancer-associated fibroblasts (CAFs) in muscle-invasive bladder cancer
Burley, Frontiers in oncology 2022 - “...the addition of concomitant 5-fluorouracil and mitomycin C to radiotherapy in the phase III UK BC2001 trial, led by James etal., provision of BST typically includes radiotherapy in combination with chemotherapy ( 11 ). This combinatorial approach can offer quality of life benefits in selected patients...”
- “...P . Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial . Eur Urol ( 2022 ) 82 ( 3 ): 2739 . doi: 10.1016/j.eururo.2022.04.017 13 El-Taji OM Alam S Hussain SA . Bladder sparing approaches for muscle-invasive bladder cancers...”
- Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer-A Review.
van, Cancers 2021 - “...This may complicate future comparisons. Recently, a meta-analysis of patients treated in the BCON and BC2001 trials confirmed the superiority of hypofractionation with 55 Gy in 20 fractions over 64 Gy in 32 fractions [ 49 ]. Despite these data, only four iCRT studies use a...”
- “...N.D. Hypofractionated radiotherapy in locally advanced bladder cancer: An individual patient data meta-analysis of the BC2001 and BCON trials Lancet Oncol. 2021 22 246 255 10.1016/S1470-2045(20)30607-0 33539743 50. Arafat W. Darwish A. Naoum G.E. Sameh W. El Husseiny G. Abd-El-Gawad F. Samir M. Comparison between standard...”
- Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial
Mintz, Pilot and feasibility studies 2020 - “...score Charlson Comorbidity Index score NIHR National Institute for Health Research MRI Magnetic resonance imaging BC2001 Bladder Cancer 2001 HR Hazard ratio CI Confidence interval PPV Positive predictive value BCG Bacillus Calmette-Gurin TURBT Transurethral resection of bladder tumour MIBC Muscle invasive bladder cancer LINAC Linear accelerator...”
- Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting
Kassouf, Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2020 - Intensity-Modulated Radiotherapy is Superior to Three-Dimensional Conformal Radiotherapy in the Trimodality Management of Muscle-Invasive Bladder Cancer with Daily Cone Beam Computed Tomography Optimization
Sherry, Journal of radiation oncology 2019 - “...in 9% of its study cohort receiving daily radiation and gemcitabine [ 14 ]. Similarly, BC2001 reported rates of 9.6% high grade gastrointestinal toxicity during 3D-CRT with mitomycin C and 5-fluorouracil, even with 40% of those patients randomized to hypofractionated dose of 55 Gy [ 26...”
- “...toxicity also appears substantially reduced given known dose-volume effects of the bladder [ 15 ]. BC2001 observed high grade genitourinary toxicity in 21% of chemoradiotherapy patients, which appears equivalent to our studys genitourinary toxicity rate of 21% [ 26 ]. However, it may be possible that,...”
- A Festschrift in Honor of Edward M. Messing, MD, FACS
Joseph, Bladder cancer (Amsterdam, Netherlands) 2018 - “...up to 50%. The importance of concurrent chemotherapy with surgery was emphasized in the randomized BC2001 trial, [ 22 ] with an improvement in 5 year overall survival from 35% to 48% when chemotherapy was added to radiation. There is a low incidence of late side...”
- More
PG0198 conserved hypothetical protein (NCBI) from Porphyromonas gingivalis W83
Aligns to 11:164 / 179 (86.0%), covers 100.0% of PF05656, 98.6 bits
EG14_04805 DUF805 domain-containing protein from Porphyromonas gingivalis
Aligns to 11:164 / 179 (86.0%), covers 100.0% of PF05656, 98.6 bits
ACIAD0937 conserved hypothetical protein; putative membrane protein (NCBI) from Acinetobacter sp. ADP1
Aligns to 116:218 / 219 (47.0%), covers 98.1% of PF05656, 96.7 bits
lmo0672 similar to unknown protein (NCBI ptt file) from Listeria monocytogenes EGD-e
LMRG_00360 hypothetical protein (RefSeq) from Listeria monocytogenes 10403S
Aligns to 14:135 / 142 (85.9%), covers 98.1% of PF05656, 92.0 bits
- RNA-Mediated Control in Listeria monocytogenes: Insights Into Regulatory Mechanisms and Roles in Metabolism and Virulence
Krawczyk-Balska, Frontiers in microbiology 2021 - “...part of a larger transcript, designated Rli33, encoded from the intergenic region of lmo0671 and lmo0672 ( Toledo-Arana et al., 2009 ). A more recent study identified two individual ncRNAs, Rli33-1 and Rli33-2, which suggests either the presence of an internal transcription start site (TSS) or...”
- Survival of Listeria monocytogenes in Soil Requires AgrA-Mediated Regulation
Vivant, Applied and environmental microbiology 2015 - “...lmo2761 lmo0412 lmo0471 lmo0471 lmo0471 lmo0518 lmo0559 lmo0561 lmo0672 lmo0830 lmo0867 lmo0919 togenes to the soil environment. It is interesting to notice...”
- The intracellular sRNA transcriptome of Listeria monocytogenes during growth in macrophages
Mraheil, Nucleic acids research 2011 - “...of mgtA . Interestingly, a putative sRNA located in the intergenic region between lmo0671 and lmo0672 was previously reported as rli33 encoding a transcript of 534nt in length ( 31 ). However, our RNA-seq revealed two smaller fragments of 186nt ( rli33-1 ) and 274nt (...”
- Amplified intergenic locus polymorphism as a basis for bacterial typing of Listeria spp. and Escherichia coli
Somer, Applied and environmental microbiology 2005 - “...or species Lmo1430 clpE BetL ATTM ltrC cheR lisR Lmo0672 Lmo0196 Lmo0075 Lin0694 Lmo0023 gid fhuB Lmo0042 Lmo0176 abc gbuA Allelea at following locus: LM6-4b...”
- Alternative σ Factors Regulate Overlapping as Well as Distinct Stress Response and Metabolic Functions in Listeria monocytogenes under Stationary Phase Stress Condition.
Orsi, Pathogens (Basel, Switzerland) 2021 - “...described as rli33 [ 44 ]. This ncRNA is located between two genes (LMRG_00359 and LMRG_00360), both encoding hypothetical proteins, and had previously been shown to be less abundant in an L. monocytogenes sigB mutant [ 44 ]; a mutant strains lacking rli33 had also previously...”
YiiR / b3921 DUF805 domain-containing protein YiiR from Escherichia coli K-12 substr. MG1655 (see paper)
Aligns to 7:133 / 146 (87.0%), covers 98.1% of PF05656, 78.3 bits
ACICU_03432 hypothetical protein (RefSeq) from Acinetobacter baumannii ACICU
Aligns to 4:118 / 171 (67.3%), covers 98.1% of PF05656, 76.7 bits
M3Q_3669 DUF805 domain-containing protein from Acinetobacter baumannii TYTH-1
Aligns to 15:129 / 182 (63.2%), covers 98.1% of PF05656, 76.5 bits
lp_1702 integral membrane protein (NCBI ptt file) from Lactobacillus plantarum WCFS1
Aligns to 12:121 / 121 (90.9%), covers 91.4% of PF05656, 75.9 bits
- Genomic Evidence for Bacterial Determinants Influencing Obesity Development.
Isokpehi, International journal of environmental research and public health 2017 - “...neighbors. Using the genome of L. plantarum WCFS1 as the reference, the genes tagged as lp_1702 and lp_1703 and respectively annotated as membrane protein and diacylglycerol kinase family protein were in the same transcription direction as the two-gene operon. 3.4. Gene Neighborhood of Gene for the...”
PA0659 hypothetical protein (NCBI) from Pseudomonas aeruginosa PAO1
Q9I5R2 DUF805 domain-containing protein from Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
Aligns to 174:277 / 358 (29.1%), covers 99.0% of PF05656, 72.2 bits
- Discovery of coordinately regulated pathways that provide innate protection against interbacterial antagonism
Ting, eLife 2022 - “...PA0090 0.85 0.53 PA1552 0.83 N.D. PA0077 0.81 5.33 PA2494 0.81 ND PA2976 0.72 0.71 PA0659 0.70 N.D. PA4761 0.70 0.44 PA4941 0.65 2.57 PA4265 0.63 0.46 PA3656 0.61 0.67 PA3794 0.61 N.D. PA2151 0.56 0.55 PA3821 0.56 N.D. * Proteins containing at least two peptides...”
- A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
Montemari, Frontiers in medicine 2022 - “...Uncharacterized protein 100 100 Q9I3G7 PA1550 Uncharacterized protein 0.01 Q9I413 PA1331 Uncharacterized protein 100 Q9I5R2 PA0659 Uncharacterized protein 0.01 Q9I6D5 PA0359 Uncharacterized protein 100 Q9HVT1 PA4490 Uncharacterized protein PA4490 100 Q9I1B3 PA2366 Uricase PuuD 0.01 pae02025 Biofilm formation Q9HU14 cysQ 3'(2'),5'-bisphosphate nucleotidase CysQ CytoplasmicMembrane/Cytoplasmic 0.01 Q9I6V6...”
- Isolation and characterization of Pseudomonas aeruginosa R' plasmids constructed by interspecific mating
Morgan, Journal of bacteriology 1982 - “...trpF leu-10 phe-2 amiE200 PAO114 PA0505 PA0473 PA0905 PA0659 PA0505 PA0904 PA0305 PA0897 argF1O argG27 pMO757 pMO758 Wild-type alleles carried by R'pMO778...”
- Defining hierarchical protein interaction networks from spectral analysis of bacterial proteomes
Zaydman, eLife 2022 - “...Kornberg, 2004 ; Figure 7A , Figure 7figure supplement 1B ). Four uncharacterized proteins (Q9I5G6, Q9I5R2, Q9I0G2, Q9I0G1) were included in the pilus subnetwork that had not previously been associated with PilA in P. aeruginosa ( Figure 7B Supplementary file 6 ). Our hierarchical models suggested...”
- “...2004 ; Rashid and Kornberg, 2004 ; Little et al., 2018 ). Transposon mutants of Q9I5R2, Q9I0G2, and Q9I0G1 exhibited motility that was not significantly different from the parent strain in both assays ( Supplementary file 7 ). In contrast, we found that two different transposon...”
- A Shaving Proteomic Approach to Unveil Surface Proteins Modulation of Multi-Drug Resistant Pseudomonas aeruginosa Strains Isolated From Cystic Fibrosis Patients
Montemari, Frontiers in medicine 2022 - “...PA2895 Uncharacterized protein 100 100 Q9I3G7 PA1550 Uncharacterized protein 0.01 Q9I413 PA1331 Uncharacterized protein 100 Q9I5R2 PA0659 Uncharacterized protein 0.01 Q9I6D5 PA0359 Uncharacterized protein 100 Q9HVT1 PA4490 Uncharacterized protein PA4490 100 Q9I1B3 PA2366 Uricase PuuD 0.01 pae02025 Biofilm formation Q9HU14 cysQ 3'(2'),5'-bisphosphate nucleotidase CysQ CytoplasmicMembrane/Cytoplasmic 0.01...”
LSA1296 Hypothetical integral membrane protein (NCBI) from Lactobacillus sakei subsp. sakei 23K
Aligns to 12:120 / 121 (90.1%), covers 90.5% of PF05656, 71.7 bits
- Global transcriptome response in Lactobacillus sakei during growth on ribose
McLeod, BMC microbiology 2011 - “...1.7 1.4 LSA1189 lsa1189 Hypothetical integral membrane protein -1.6 -1.1 LSA1282 lsa1282 Hypothetical protein -0.5 LSA1296 lsa1296 Hypothetical integral membrane protein -1.2 -0.8 LSA1342 lsa1342 Hypothetical protein -0.7 LSA1346 lsa1346 Hypothetical protein 0.8 LSA1350 lsa1350 Hypothetical protein -0.6 -1.0 LSA1353 lsa1353 Hypothetical integral membrane protein -0.9...”
SACOL2338 hypothetical protein (NCBI) from Staphylococcus aureus subsp. aureus COL
Q2FVS2 DUF805 domain-containing protein from Staphylococcus aureus (strain NCTC 8325 / PS 47)
SAOUHSC_02620 hypothetical protein (NCBI) from Staphylococcus aureus subsp. aureus NCTC 8325
SAUSA300_2289 hypothetical protein (NCBI) from Staphylococcus aureus subsp. aureus USA300_FPR3757
Aligns to 20:180 / 215 (74.9%), covers 100.0% of PF05656, 66.5 bits
- Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray.
Schwan, Antibiotics (Basel, Switzerland) 2017 - “...2.5 succinate dehydrogenase, cytochrome b558 subunit ( sdhC ) SACOL1604 2.1 glucokinase ( glk ) SACOL2338 3.5 hypothetical protein (putative oxidoreductase) SACOL1713 2.3 hypothetical protein, putative ammonia monooxygenase Unknown SACOL0089 4.4 myosin-reactive antigen, 67 kDa SACOL2315 3.8 conserved hypothetical protein SACOL2338 3.4 conserved hypothetical protein SACOL2491...”
- A Small Membrane Stabilizing Protein Critical to the Pathogenicity of Staphylococcus aureus.
Duggan, Infection and immunity 2020 - “...Q2G294 Acetyl-coenzyme A synthetase 2.1 0.001 Q2FZI6 purH Bifunctional purine biosynthesis protein PurH 2.2 <0.0001 Q2FVS2 Uncharacterized protein 2.2 0.001 Q2G2P7 hutH Histidine ammonia-lyase 2.2 0.006 Q2FW51 Truncated major histocompatibility complex class II analog protein 2.2 0.015 Q2FVQ4 l -Lactate permease 2.2 0.006 Q2FV59 crtM Dehydrosqualene...”
- Lysogenization of Staphylococcus aureus RN450 by phages ϕ11 and ϕ80α leads to the activation of the SigB regulon
Fernández, Scientific reports 2018 - “...SAOUHSC_02451 0.44 0.49 SAOUHSC_02452 lacD 0.38 0.45 SAOUHSC_02453 lacC 0.39 0.49 SAOUHSC_02597 2.12 2.90 Up SAOUHSC_02620 0.45 0.24 Down SAOUHSC_02729 2.20 3.14 Up SAOUHSC_02771 2.96 5.46 Up SAOUHSC_02772 2.32 6.49 Up SAOUHSC_02812 3.00 7.98 Up SAOUHSC_02815 2.63 4.38 Up SAOUHSC_02822 fbp 2.31 3.17 Up SAOUHSC_02848 glcB...”
- Prediction driven functional annotation of hypothetical proteins in the major facilitator superfamily of S. aureus NCTC 8325
Marklevitz, Bioinformation 2016 - “...well-defined function is more likely related. SAOUHSC_02307, SAOUHSC_02309, and ABD31816.1 hit several general membrane proteins. SAOUHSC_02620 and SAOUHSC_02866 matched several hypothetical proteins as well as general membrane proteins. This indicates these hypothetical proteins may not be in the MFS. Table 5 lists the physiochemical parameters calculated...”
- “...Four of the five hypothetical proteins that had ambiguous membrane protein BLASTP hits, SAOUHSC_02307, SAOUHSC_02309, SAOUHSC_02620, and SAOUHSC_02866, came up outside this size range. Examination of other physiochemical calculations failed to be consistent in predicting MFS proteins among hypotheticals though some proteins outside this size range...”
- Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus
Kumaraswamy, Microorganisms 2021 - “...biotin carboxylase HMPREF0776_2830 Excalibur domain protein SAUSA300_0460 Uncharacterized protein hflB ftsH ATP-dependent zinc metalloprotease FtsH SAUSA300_2289 Uncharacterized protein isdB Iron-regulated surface determinant protein B srrA Staphylococcal respiratory response protein, SrrA codY GTP-sensing transcriptional pleiotropic repressor CodY SAUSA300_0816 UPF0337 protein SAUSA300_0816 rpsD 30S ribosomal protein S4 HMPREF0776_2441...”
- Staphylococcus aureus ClpX localizes at the division septum and impacts transcription of genes involved in cell division, T7-secretion, and SaPI5-excision
Jensen, Scientific reports 2019 - “...toxin-antitoxin system (type VII secretion locus) 0,6 4,6E-03 SAUSA300_0271 ABC transporter ATP-binding protein 0,6 5,2E-03 SAUSA300_2289 hypothetical protein 0,6 4,5E-04 copZ copper chaperone copZ 0,6 7,3E-05 esxC EsxC toxin (type VII secretion locus) 0,6 6,2E-03 SAUSA300_0273 hypothetical protein 0,6 6,7E-08 nrdD anaerobic ribonucleoside triphosphate reductase 0,6...”
- VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus
Boyle-Vavra, Antimicrobial agents and chemotherapy 2013 - “...Transporter Hypothetical Transporter Membrane spanning SAUSA300_2288 SAUSA300_2289 SAUSA300_2453 SAUSA300_2454 SA2132 SA2133 SA2302 SA2303 2.2 4.3 2.2 2.4 3.5...”
SA2133 hypothetical protein (NCBI) from Staphylococcus aureus subsp. aureus N315
Aligns to 20:180 / 206 (78.2%), covers 100.0% of PF05656, 66.5 bits
MW2263 conserved hypothetical protein (NCBI ptt file) from Staphylococcus aureus subsp. aureus MW2
Aligns to 20:180 / 206 (78.2%), covers 100.0% of PF05656, 66.5 bits
SAR2428 putative membrane protein (NCBI) from Staphylococcus aureus subsp. aureus MRSA252
Aligns to 20:180 / 215 (74.9%), covers 100.0% of PF05656, 65.8 bits
- Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer
Doyle, The Journal of antimicrobial chemotherapy 2009 - “...SAR1423 0.46 Hypothetical protein femA 0.49 Peptidogylcan biosynthesis and methicillin resistance murF 0.49 Peptidogylcan biosynthesis SAR2428 0.49 Putative membrane protein Table 4 Comparison of microarray, proteomic and qRT-PCR data after addition of ELB-21 (0.5 MIC) to cultures of EMRSA-16 Gene Microarray Proteomics qRT-PCR a recA 5.24...”
- The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications
Kenny, PloS one 2009 - “...protein 2.04 3.47E-03 SAR2369 putative acyl-CoA dehydrogenase 2.86 1.94E-03 SAR2425 putative membrane protein 2.13 5.63E-03 SAR2428 putative membrane protein 2.00 3.23E-03 SAR2435 putative acyl hydrolase 2.50 3.02E-02 SAR2439 tetR family regulatory protein 2.22 3.23E-03 SAR2473 putative exported protein 3.85 3.97E-03 SAR2500 putative lipoprotein 2.86 8.48E-04 SAR2546...”
- “...2.38 3.02E-03 SAR2426 putative membrane protein 2.09 2.11E-03 SAR2427 ABC transporter ATP-binding protein 2.14 4.82E-03 SAR2428 putative membrane protein 3.73 1.21E-05 SAR2569 hypothetical protein 6.01 4.75E-02 10.1371/journal.pone.0004344.t004 Table 4 MRSA252 genes down-regulated during growth in the presence of linoleic acid (0.01mM ) (linoleic acid growth exposure)....”
c0036 Hypothetical protein (NCBI ptt file) from Escherichia coli CFT073
LF82_004 DUF805 domain-containing protein from Escherichia coli LF82
Aligns to 14:121 / 121 (89.3%), covers 92.4% of PF05656, 62.9 bits
PMT1567 conserved hypothetical protein (NCBI) from Prochlorococcus marinus str. MIT 9313
Aligns to 14:107 / 108 (87.0%), covers 91.4% of PF05656, 62.8 bits
EF1089 conserved hypothetical protein (NCBI ptt file) from Enterococcus faecalis V583
Aligns to 12:124 / 131 (86.3%), covers 89.5% of PF05656, 62.7 bits
SSA_0718 Conserved uncharacterized protein (NCBI) from Streptococcus sanguinis SK36
Aligns to 12:165 / 364 (42.3%), covers 98.1% of PF05656, 60.2 bits
A1S_3236 hypothetical protein (RefSeq) from Acinetobacter baumannii ATCC 17978
Aligns to 2:84 / 137 (60.6%), covers 60.0% of PF05656, 59.5 bits
- An ribonuclease T2 family protein modulates Acinetobacter baumannii abiotic surface colonization
Jacobs, PloS one 2014 - “...pilN/comN fibrial assembly protein gi-126643206 3.5 11.9 A1S_3195 comM competence protein A gi-126643244 2.8 4 A1S_3236 hypothetical protein gi-126643330 2.3 10.7 A1S_3323 putative flavoprotein 1 ATCC17978 locus tag; adjacent loci are highlighted in grey; loci associated with pili formation and motility are bolded. To further verify...”
- “...RNA binding/nucleotide hydrolase), A1S_1476 (tautomerase/hydrolase), A1S_2787 (limited homology to Bartonella cell invasion associated protein) and A1S_3236 (homology to tRNA transferase/hydrolase) did not provide additional insight regarding how A1S_3026 modulates abiotic surface colonization. Thus, we surmise that the RNase T2 family protein-associated biofilm formation phenotype is predominately...”
LSA1480 Hypothetical membrane protein (NCBI) from Lactobacillus sakei subsp. sakei 23K
Aligns to 24:161 / 168 (82.1%), covers 86.7% of PF05656, 45.2 bits
- Global transcriptome response in Lactobacillus sakei during growth on ribose
McLeod, BMC microbiology 2011 - “...Hypothetical protein 0.6 LSA1464 lsa1464 Hypothetical protein -0.6 LSA1478 lsa1478 Hypothetical protein -0.7 -0.6 -0.6 LSA1480 lsa1480 Hypothetical membrane protein 0.5 D LSA1524 lsa1524 Hypothetical protein 0.8 LSA1539 lsa1539 Hypothetical protein 0.9 LSA1713 lsa1713 Hypothtical small peptide -0.6 LSA1787 lsa1787 Hypothetical cell surface protein precursor -0.5...”
llmg_1683 hypothetical protein (NCBI) from Lactococcus lactis subsp. cremoris MG1363
Aligns to 12:166 / 173 (89.6%), covers 74.3% of PF05656, 43.3 bits
YPO0751 putative membrane protein (NCBI ptt file) from Yersinia pestis CO92
Aligns to 1:92 / 93 (98.9%), covers 83.8% of PF05656, 43.0 bits
WP_019293277 DUF805 domain-containing protein from Lactococcus petauri
Aligns to 12:128 / 129 (90.7%), covers 94.3% of PF05656, 34.8 bits
- Characterization of prophages of Lactococcus garvieae
Eraclio, Scientific reports 2017 - “...20 10180 9791 129 15 9.2 AGGtaAatATG Membrane prot. L. garvieae 121/129 (94%) 2.0E-83 129 WP_019293277 21 + 10373 10579 68 7 4.8 AGGAGAataaaacATG L. lactis 52/68 (76%) 5.0E-25 68 WP_012897654 22 + 10585 10818 77 9 10.6 tGGAGAataagtcaaATG L . garvieae 32/52 (62%) 2.0E-10 73...”
Or search for genetic data about PF05656 in the Fitness Browser
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory